About Emcee Pharmaceuticals Pvt Ltd
Data last updated:
Emcee Pharmaceuticals Pvt Ltd is a private limited company based in Kalyani, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 May 1978 and has been in existence for over 48 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB1978PTC031482. Its GSTIN is 19AAACE5456F1ZN (West Bengal).
The company has an authorised share capital of ₹90 Lakh and a paid-up capital of ₹41.76 Lakh. It is led by directors including Shampa Moitra and Sudeep Basu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 10 Industrial Estate Kalyani P.S – Kalyani P.O – Kalyani, West Bengal, India – 741235.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.02 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹3.52 Cr (net margin 11.4%) and EBITDA of ₹5.3 Cr (EBITDA margin 17.1%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 14% over five years.
The company has about 223 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.43 Cr and satisfied charges of ₹40 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website emceepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressS – 10 Industrial Estate Kalyani P.S – Kalyani P.O – Kalyani, West Bengal, India – 741235
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Emcee Pharmaceuticals Pvt Ltd
The main business activity of Emcee Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Emcee Pharmaceuticals Pvt Ltd FY 2025 filings available
Emcee Pharmaceuticals Pvt Ltd reported revenue of ₹31.02 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Emcee Pharmaceuticals Pvt Ltd
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 14% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Emcee Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.3 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.52 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Emcee Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emcee Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Emcee Pharmaceuticals Pvt Ltd
Emcee Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmaceutical Institute of India Private Limited | ₹31.28 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Cuttack, Odisha, India |
| Bangalore Pharmaceutical and Research Laboratory Private Limited | ₹31.23 Cr (FY 2023) | •••• | •••• | 20.0% | •••• | Bangalore, Karnataka, India |
| Fertin India Private Limited | ₹31.2 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Salcete, Goa, India |
| Ja Sterile Private Limited | ₹31.15 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Visnagar, Gujarat, India |
| Indisuan Pharmaceuticals Private Limited | ₹31.12 Cr (FY 2025) | •••• | •••• | -55.0% | •••• | Navi Mumbai, Maharashtra, India |
| Emcee Pharmaceuticals Pvt Ltd this company | ₹31.02 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Kalyani, West Bengal, India |
| Krish Chemicals Private Limited | ₹31.02 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Sarigam, Gujarat, India |
| Furfur Agro Oils Private Limited | ₹31 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Solapur, Maharashtra, India |
| Delvin Formulations Private Limited | ₹30.87 Cr (FY 2023) | •••• | •••• | 26.0% | •••• | Kanchipuram, Tamil Nadu, India |
| Medifuture Pharmaceuticals Private Limited | ₹30.78 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | Delhi, India |
| Puneet Laboratories Private Limited | ₹30.72 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Emcee Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Emcee Pharmaceuticals Pvt Ltd
Emcee Pharmaceuticals Pvt Ltd is audited by GUPTA & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GUPTA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Emcee Pharmaceuticals Pvt Ltd
Emcee Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shampa Moitra | Director | 05 Sep 2003 | 23 Years 1 Months | Current |
| Sudeep Basu | Director | 05 Sep 2003 | 23 Years 1 Months | Current |
| Utpal Moitra | Director | 17 Feb 1992 | 34 Years 7 Months | Current |
| Arindam Dasgupta | Additional Director | 02 Jan 2025 | 1 Years 9 Months | Current |
Ownership and Shareholding of Emcee Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Emcee Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2005 | State Bank of India | ₹3.53 Cr | Open |
| 18 Mar 2004 | State Bank of India | ₹90 Lakh | Open |
| 17 Mar 2005 | Small Industrial Development Bank of India | ₹40 Lakh | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Emcee Pharmaceuticals Pvt Ltd
Emcee Pharmaceuticals Pvt Ltd has 2 court cases on record: 1 filed by Emcee Pharmaceuticals, 1 filed against it. 1 case is pending and 1 is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Civil suit | Filed by the company against Centaur Laboratories Private Limited | Pending |
| Calcutta High Court | Civil suit | Filed against the company by Centaur Laboratories Private Limited | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Emcee Pharmaceuticals Pvt Ltd
Emcee Pharmaceuticals Pvt Ltd has a workforce of 223 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Emcee Pharmaceuticals Pvt Ltd
Emcee Pharmaceuticals Pvt Ltd has 4 board changes on record since 1992: 4 appointments. The latest: Arindam Dasgupta was appointed as Additional Director on 02 Jan 2025.
Credit Ratings, Litigation & Regulatory Alerts for Emcee Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Emcee Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Emcee Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Emcee Pharmaceuticals Pvt Ltd
Emcee Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAACE5456F1ZN | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Emcee Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emcee Pharmaceuticals Pvt Ltd
Emcee Pharmaceuticals is an active private limited company based in Kalyani, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 May 1978 (48+ years old) and is registered under CIN U24239WB1978PTC031482.
Emcee Pharmaceuticals reported revenue of ₹31.02 Cr for FY 2025 (up 14% YoY).
Emcee Pharmaceuticals has 4 current directors:
- Shampa Moitra - Director
- Sudeep Basu - Director
- Utpal Moitra - Director
- Arindam Dasgupta - Additional Director
Emcee Pharmaceuticals reported a net profit of ₹3.52 Cr (net margin 11.4%) and EBITDA of ₹5.3 Cr (EBITDA margin 17.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Emcee Pharmaceuticals is 13% over three years and 14% over five years. In the latest year (FY 2025) revenue rose 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Emcee Pharmaceuticals is 19AAACE5456F1ZN, registered in West Bengal.
The CIN (Corporate Identification Number) of Emcee Pharmaceuticals is U24239WB1978PTC031482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emcee Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.
Emcee Pharmaceuticals was incorporated on 09 May 1978, making it 48+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Emcee Pharmaceuticals by revenue are Pharmaceutical Institute of India Private Limited, Bangalore Pharmaceutical and Research Laboratory Private Limited, Fertin India Private Limited, Ja Sterile Private Limited, Indisuan Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Arindam Dasgupta was appointed as Additional Director on 02 Jan 2025. Shampa Moitra was appointed as Director on 05 Sep 2003. Sudeep Basu was appointed as Director on 05 Sep 2003. Emcee Pharmaceuticals has 4 board changes on record in total.